Evidence map›Paper›PMID 37376631›Full record

ArticleViruses2023

Deoptimization of FMDV P1 Region Results in Robust Serotype-Independent Viral Attenuation.

Gisselle N Medina, Edward Spinard, Paul A Azzinaro, Monica Rodriguez-Calzada, Joseph Gutkoska, Anna Kloc, Elizabeth A Rieder, Bruce E Taillon, Stephen Mueller, Teresa de Los Santos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Gisselle N MedinaPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.ORCID 0000-0002-8663-3786
Edward SpinardPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.ORCID 0000-0001-7268-6580
Paul A AzzinaroPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.ORCID 0000-0002-0172-6415
Monica Rodriguez-CalzadaPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.
Joseph GutkoskaPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.
Anna KlocDepartment of Biology and Environmental Sciences, University of New Haven, West Haven, CT 06516, USA.
Elizabeth A RiederPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.
Bruce E TaillonCodagenix, Inc., Farmingdale, NY 11735, USA.
Stephen MuellerCodagenix, Inc., Farmingdale, NY 11735, USA.
Teresa de Los SantosPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.ORCID 0000-0003-3075-4316
Fayna Diaz-San SegundoPlum Island Animal Disease Center (PIADC), ARS, USDA, Greenport, NY 11944, USA.
Plum Island Animal Disease Center · USCodagenix (United States) · USCenter for Grain and Animal Health Research · USNational Institutes of Health · USUniversity of New Haven · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foot-and-mouth disease (FMD), caused by the FMD virus (FMDV), is a highly contagious disease of cloven-hoofed livestock that can have severe economic impacts. Control and prevention strategies, including the development of improved vaccines, are urgently needed to effectively control FMD outbreaks in endemic settings. Previously, we employed two distinct strategies (codon pair bias deoptimization (CPD) and codon bias deoptimization (CD)) to deoptimize various regions of the FMDV serotype A subtype A12 genome, which resulted in the development of an attenuated virus in vitro and in vivo, inducing varying levels of humoral responses. In the current study, we examined the versatility of the system by using CPD applied to the P1 capsid coding region of FMDV serotype A subtype, A24, and another serotype, Asia1. Viruses carrying recoded P1 (A24-P1Deopt or Asia1-P1Deopt) exhibited different degrees of attenuation (i.e., delayed viral growth kinetics and replication) in cultured cells. Studies in vivo using a mouse model of FMD demonstrated that inoculation with the A24-P1Deopt and Asia1-P1Deopt strains elicited a strong humoral immune response capable of offering protection against challenge with homologous wildtype (WT) viruses. However, different results were obtained in pigs. While clear attenuation was detected for both the A24-P1Deopt and Asia1-P1Deopt strains, only a limited induction of adaptive immunity and protection against challenge was detected, depending on the inoculated dose and serotype deoptimized. Our work demonstrates that while CPD of the P1 coding region attenuates viral strains of multiple FMDV serotypes/subtypes, a thorough assessment of virulence and induction of adaptive immunity in the natural host is required in each case in order to finely adjust the degree of deoptimization required for attenuation without affecting the induction of protective adaptive immune responses.

Indexed as

Foot-and-Mouth DiseaseFoot-and-Mouth Disease VirusViral VaccinesAnimalsAntibodies, ViralCapsid ProteinsSerogroupSwineAntibodies, ViralCapsid ProteinsViral Vaccinescodon-pair biasdeoptimizationFMDVfoot-and-mouth diseasepicornavirusvaccines

Identifiers

PMID37376631
PMCPMC10301631
OpenAlexW4379649080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.